Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call

Furiex Pharmaceuticals, Inc. will release its second quarter 2011 financial results on Wednesday, August 3, 2011, after the market closes. The earnings news release will be available on the Furiex website at www.furiex.com .On Thursday, August 4, 2011, at 9 a.m. ET, Furiex will conduct a live conference call and audio webcast to discuss financial results and product portfolio. A Q&A session will follow. The conference call will be broadcast live over the Internet and will also be available using the following direct dial numbers: Participant dial-in: +1 877 267 0934 (U.S./Canada) +1 706 643 0961 (International) Conference ID: 80507394 All interested parties can access the webcast through the Presentations & Events link in the Investors section of the Furiex website at www.furiex.com . The webcast will be archived shortly after the call for on-demand replay.About Furiex PharmaceuticalsFuriex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by advancing them through the drug discovery and development process in a cost-efficient manner. Development programs are designed and driven by a core team with extensive drug development experience. The company collaborates with pharmaceutical and biotechnology companies and has a strong, diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and two products on the market. The company's mission is to develop innovative medicines faster and at less cost, reducing the expense of health care globally while providing life-improving therapies for patients